Medical News

RSS

4medica to present IHR solution at Interoperability Showcase in Atlanta

4medica, the leading independent provider of Web-based connectivity between physicians and clinical laboratories, announced today that it will demonstrate the versatility of its Integrated Health Record (IHR™) solution at the 2010 Annual Healthcare Information and Management Systems Society (HIMSS) Interoperability Showcase at booth #233 in Hall C of the Georgia World Congress Center in Atlanta from March 1-3, 2010.

25 Feb 2010

Kinex Pharmaceuticals announces KX2-391 Phase 2 safety and efficacy clinical trial in men with CRPC

Kinex Pharmaceuticals opened a Phase 2 clinical trial to evaluate the safety and efficacy of KX2-391 in patients with bone-metastatic, castrate-resistant prostate cancer (CRPC) who have not had prior chemotherapy.

25 Feb 2010

Beyond Blair House: Discussion of public option, 'Cadillac tax' continue

As lawmakers and President Obama discuss health care at the Blair House summit, news reports ply two policy issues in the latest overhaul proposal, the public option and the "Cadillac tax."

25 Feb 2010

Reid upset after Republicans block COBRA benefits extension request

Roll Call: Senate Majority Leader Harry Reid criticized Republicans Wednesday after the GOP denied "a unanimous consent request to pass an extension of unemployment insurance and COBRA health care benefits, a move he warned would leave 'out-of-work Americans vulnerable to losing this valuable safety net'" (Brady, 2/24).

25 Feb 2010

E. Fougera receives first generic approval for Imiquimod Cream 5%

E. Fougera & Co., a leading specialty pharmaceutical manufacturer, today announced it has received first generic approval from the FDA for Imiquimod Cream 5% (Rx). Fougera's Imiquimod Cream 5% is rated AB, generically equivalent to Aldara® by Graceway Pharmaceuticals and substitutable for all indications. According to industry data, U.S. sales of the brand named product in 2009 exceed $360 million.

25 Feb 2010

WellPoint executive defends premium increases at congressional hearing

In a congressional hearing Wednesday, an insurance company executive justified proposed premium increases and warned "that pending legislation" could make the problem of high medical costs worse. "The executive, Angela F. Braly, president of WellPoint, made the comments in testimony prepared for a hearing of the House Energy and Commerce Committee," The New York Times reports.

25 Feb 2010

Patented chemical derived from sugar may be an alternative for BPA

Michael Jaffe, a professor of biomedical engineering at NJIT, has received a patent for a chemical derived from sugar. This new material is a derivative of isosorbide and may be able to replace bisphenol A (BPA) in a number of consumer products, including the lining of tin cans.

25 Feb 2010

FDA sets new PDUFA action date for exenatide once weekly NDA

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has set a new Prescription Drug User Fee Act (PDUFA) action date of March 12 for its review of the exenatide once weekly new drug application (NDA).

25 Feb 2010

SonoSite announces final results of modified “Dutch Auction” tender offer

SonoSite, Inc., the world leader and specialist in hand-carried ultrasound for the point-of-care, today announced the final results of its modified “Dutch Auction” tender offer which expired at 5:00 p.m. New York City time on February 19, 2010.

25 Feb 2010

Biovail reports 33% increase in total revenues for fourth-quarter 2009

Biovail Corporation today announced financial results for the three-month and 12-month periods ending December 31, 2009.

25 Feb 2010

Impax Laboratories announces record net income of $0.61 per diluted share for fourth-quarter 2009

Impax Laboratories, Inc. today reported its strongest financial results in its history due to record sales from its Global products sales channel.

25 Feb 2010

Symmetry Medical reports gross profit of $14.0M for fourth-quarter 2009

Symmetry Medical Inc., a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced fourth quarter and full year 2009 financial results for the period ended January 2, 2010.

25 Feb 2010

NeoGenomics' fourth-quarter revenue up 32%

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported its results for the fourth quarter 2009 and fiscal year ended December 31, 2009.

25 Feb 2010

CFIA approves export of Neovasc's processed pericardial tissue products to Europe

Neovasc Inc., today announced that it has received Canadian Food Inspection Agency (CFIA) approval to export its processed pericardial tissue products to Europe as an "intermediate product" under the requirements of Annex I of EC Regulation # 2007/2006. This approval allows European customers to import Neovasc's porcine and bovine pericardial tissue materials for use in the manufacture of their own medical devices.

25 Feb 2010

Nightingale reports revenue of $4.4M for third-quarter fiscal 2010

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the quarter and nine months ended December 31, 2009. All results are reported in Canadian dollars unless otherwise stated.

25 Feb 2010

Sales revenue from Labopharm's once-daily tramadol increases to $4.7M for fourth-quarter fiscal 2009

Labopharm Inc. today reported its financial results for the fourth quarter and fiscal year ended December 31, 2009. All figures are in Canadian dollars unless otherwise stated.

25 Feb 2010

NxStage Medical reports net revenue of 15% for twelve months ended December 31, 2009

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported financial results for the three months and twelve months ended December 31, 2009, that include revenue and Adjusted EBITDA results above the top end of its guidance ranges.

25 Feb 2010

Teleflex enters into definitive agreement to sell its SSI Surgical Services for $25 million

Teleflex Incorporated, a leading global provider of medical technology products, today announced that it has entered into a definitive agreement to sell its SSI Surgical Services Inc. business to a privately-owned multi-service line healthcare company for approximately $25 million. The transaction is subject to customary closing conditions and is expected to close before the end of the first quarter of 2010.

25 Feb 2010

Regulus Therapeutics, GSK announce new collaboration on microRNA therapeutics targeting microRNA-122

Regulus Therapeutics Inc. today announced the establishment of a new collaboration with GlaxoSmithKline (GSK) to develop and commercialize microRNA therapeutics targeting microRNA-122 in all fields with Hepatitis C Viral infection (HCV) as the lead indication. Under the terms of the new collaboration, Regulus will receive additional upfront and early-stage milestone payments with the potential to earn more than $150 million in miR-122-related combined payments, and tiered royalties up to double digits on worldwide sales of products.

25 Feb 2010

MiMedx Group completes corporate and technology branding initiative

MiMedx Group, Inc. announced today that it has completed its corporate and technology branding initiative. In concert with its branding initiative, the Company also announced that it has recently launched an updated website.

25 Feb 2010